Skip to content
Catalyst

theophyllineFinding

Theophylline has no detected effect on forced expiratory volume in one second (FEV1)

no difference foundVery limited evidenceFinding

01 · The sentence it was drawn from

“Low-dose theophylline had no significant effects on lung function (i.e. FEV1), incidence of pneumonia, mortality, breathlessness or measures of quality of life or disease impact.”
Quoted verbatim from Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
This finding among the 12 findings on its endpoint

theophylline

Forced expiratory volume in one second (FEV1)

no difference found

Who
Adults with COPD (FEV1/FVC < 0.7) at high risk of exacerbation, on a drug regimen including inhaled corticosteroids in both arms, with two or more treated exacerbations in the previous year
Dose studied
200 mg once or twice a day, determined by ideal body weight and smoking status

Very limited evidencePMID 31343402 · 2019

02 · The study

Study
RCT
Duration
12 months

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7G4343NSH3Z39HXRF3SRB8S